DrugPatentWatch

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Patent: 5,602,133

Summary for Patent: 5,602,133

Title: Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
Abstract:Novel methods of using thiazolidinone derivatives and related antihyperglycemic agents to treat populations at risk for developing noninsulin-dependent diabetes mellitus (NIDDM) and complications arising therefrom are disclosed. In one embodiment, the compounds of the invention are used to treat polycystic ovary syndrome in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus. In another embodiment, the compounds of the invention are used to treat gestational diabetes in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus.
Inventor(s): Antonucci; Tammy (Meguon, WI), Lockwood; Dean (Ann Arbor, MI), Norris; Rebecca (Kewadin, MI)
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Application Number:08/469,398
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form; Compound;
Patent PDF download available with subscription

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Sankyo
PRELAY
troglitazone
TABLET;ORAL020719Jan 29, 1997DISCNNo5,602,133<disabled>ADMINISTRATION TO A HOST SUFFERING FROM GESTATIONAL DIABETES
Sankyo
PRELAY
troglitazone
TABLET;ORAL020719Aug 4, 1997DISCNNo5,602,133<disabled>ADMINISTRATION TO A HOST SUFFERING FROM GESTATIONAL DIABETES
Pfizer Pharms
REZULIN
troglitazone
TABLET;ORAL020720Jan 29, 1997DISCNNo5,602,133<disabled>ADMINISTRATION TO A HOST SUFFERING FROM GESTATIONAL DIABETES
Pfizer Pharms
REZULIN
troglitazone
TABLET;ORAL020720Aug 4, 1997DISCNNo5,602,133<disabled>ADMINISTRATION TO A HOST SUFFERING FROM GESTATIONAL DIABETES
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

Patent activity for: 5,602,133

Failure to pay maintenance fee
Patent Number:5,602,133 Application Number:08/469,398 Issue Date:Feb 11 1997 Expiration Date:Feb 11 2009

International Patent Family for Patent: 5,602,133

Country Document Number Publication Date
Austria489952Dec 15, 2010
Austria376829Nov 15, 2007
Austria303147Sep 15, 2005
Austria198045Dec 15, 2000
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.


« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc